Seroprevalence and determinants of hepatitis B viral status in pregnant women attending antenatal clinics in an urban community of Oyo state, South-West Nigeria

Authors

  • Ajibola Idowu Department of Medicine, Bowen University Teaching Hospital, Ogbomoso, Nigeria
  • Oluseyi Kikelomo Israel Department of Medicine, Bowen University Teaching Hospital, Ogbomoso, Nigeria
  • Olatayo Ayodele Aremu Department of Medicine, Bowen University Teaching Hospital, Ogbomoso, Nigeria
  • Adebowale Femi Akinwumi Department of Community Health, Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20194467

Keywords:

Hepatitis B virus, Knowledge, Vaccination, Hepatitis B surface antigen, Pregnant women, Nigeria

Abstract

Background: The burden of hepatitis B virus (HBV) is assuming an epidemic proportion globally, causing grave hepatic and other complications. Mother-to-child transmission is one of the main ways of acquiring the disease. It is thus incumbent on researchers to delve more into the epidemiology of HBV. The objectives of this study is to assess respondents’ knowledge on HBV, estimated the burden of the disease among pregnant women attending antennal clinics in Ogbomoso, Nigeria and identified significant determinants of HBV positive status of the participants.

Methods: This facility-based cross-sectional study was conducted among 168 pregnant women recruited using systematic random technique. Pretested interviewer-administered, semi-structured questionnaire was used for data collection. Both descriptive and inferential statistics were carried out.

Results: Mean age of the respondents was 34±10 years, 90.5% of the respondents were 20-40 years old. HBV awareness level among the respondents was 51.8% and more than half (59.5%) of them possessed poor knowledge of the virus. Twelve percent (12.0%) of the respondents were seropositive for hepatitis B surface antigen (HBsAg). Significant determinants of HBsAg positivity were; Level of education (AOR=0.11, CI=1.56-3.47), Socio-economic class (AOR=3.23, CI=1.48-3.02) and family type (AOR=4.51, CI=0.19-0.35).

Conclusions: The burden of HBV was high among pregnant women in the study population. Awareness and knowledge of the respondent was low. Authors recommend aggressive awareness campaigns on the disease. Improving the socio-economic conditions of women will go a long way in reducing the scourge of this dreadful disease in Nigeria.

References

Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529-38.

World Health Organization: Fact sheet. Available at: http://www.who.int/news-room/fact-sheet/detail/ hepatitis-b. Accessed on 30 July 2019.

WHO Hepatitis B. 2014. Available at: http://www who.inf/inf-s/en/fact204.html. Accessed on 30 July 2019.

Ezegbudo CN, Agbonlahor DE, Nwobu GO, Igwe CU, Agba MI, Okpala HO. The Sero-prevalence of Hepatitis B surface antigen and Human Immunodeficiency Virus (HIV) among pregnant women in Anambra State. Shiraz E-Medical J. 2004,5(2):1-8.

Hou J, Liu Z, Gu F. Epidemiology and prevention of Hepatitis B virus infection. Int J Med Sci. 2005;2:50-7.

Luka SA, Ibrahim MB, Iliya SN. Seroprevalence of hepatitis B surface antigen among pregnant women attending Ahmadu Bello University Teaching Hospital Zaria. Nigerian J Parasitol. 2008;29:38–41.

Mamadou S, Ide M, Maazou AR, Aoula B, Labo S, Bozari M. HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa. HIV AIDS (Auckl). 2012;4:1-4.

Adebola TO, Akin O, Balogun MS, Ajudua A, Nguku P, et al. Seroprevalence of Hepatitis B infection in Nigeria: A national survey. Am J Trop Med Hygiene. 2016;95:902-7.

Atilola G, Obadara T, Randle M, Komolafe IO, Odutola G, Olomu J, et al. Epidemiolgy of Hepatitis B virus in pregnant women, South West Nigeria. J Epidemiol Global Health. 2018;8(3-4):115-23.

Odusanya OO. Hepatitis B virus vaccine: The Nigeria Story. J Obafemi Awolowo Univ Med Student's Association (IFEMED). 2008;14(1):4-5

Omotowo IB, Meka IA, Ijioma UN, Okoli VE, Obienu O, Nwagha T, et al. Uptake of Hepatitis B vaccination and its determinants among healthcare workers in a tertiary health facility in Enugu, South East Nigeria. BMC Infectious diseases. 2018. Available at: http://doi.org/10.1186/s12879-018-3191-9. Accessed on 30 July 2019.

Adade RB. Prevalence of Hepatitis B Among Pregnant Women in Ghana. 2016. Available at: http://197.255.68.203/handle/123456789/21775. Accessed on 30 July 2019.

Kirbak ALS, Zipporah N, Omolo J, Idris H, Usman A, Mbabazi WB. Sero-prevalence for Hepatitis B virus among pregnant women attending antenatal clinic in Juba Teaching Hospital, Republic of South Sudan. Pan African Med J. 2017;26:72.

Noubiap JJN, Nansseu JRN, Ndoula ST, Bigna JJR, Jingi AM, Fokom-Domgue J. Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon. BMC Public Health. 2015;15(1):454.

Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open. 2014;4(11):e005889.

Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J. 2011;8:12.

Olokoba AB, Salawu FK, Danburam A, Olokoba LB, Midala JK, Badung LH, et al. Hepatitis B virus infection amongst pregnant women in North-Eastern Nigeria- A call for action. Nigerian J Clin Prac. 2011;14:10-3

Eyong EM, Yankam BM, Seraphine E, Ngwa CH, Nkfusai NC, Anye CS, et al. The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka health districts of the South West region of Cameroon: a three-year retrospective study. The Pan African Med J. 2019;32:122.

Obi RR, Umeh SC, Okurede OH, Iroagba II. Prevalence of hepatitis B virus infection among pregnant women in an antenatal clinic in Port Harcourt, Nigeria. African Journal of Clinical and Experimental Microbiology. 2006;7(6):78-82.

Nongo BH, Agida TE, Oghenebuk U, Yunusa T. Seroprevalence of hepatitis B virus among antenatal attendees at the University of Abuja Teaching Hospital, Nigeria. Ann Nigerian Med. 2016;10:58-62.

Ngaira JAM, Kimotho J, Mirigi I, Osman S, Ng’ang’a Z, Lwembe R, et al. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan African Med J. 2016;24:315.

Aindou M, Voirin N, Troalen D, Abaine A, Chevallier-Queyron P, Ecochard R, et al. Socio-demographic and behavioural determinants of hepatitis B vaccination and infection in pregnant women on Mayotte Island, Indian Ocean. Vaccine. 2013;31(43):4946-52.

Downloads

Published

2019-09-26

How to Cite

Idowu, A., Israel, O. K., Aremu, O. A., & Akinwumi, A. F. (2019). Seroprevalence and determinants of hepatitis B viral status in pregnant women attending antenatal clinics in an urban community of Oyo state, South-West Nigeria. International Journal Of Community Medicine And Public Health, 6(10), 4139–4144. https://doi.org/10.18203/2394-6040.ijcmph20194467

Issue

Section

Original Research Articles